Navigation Links
Ingenuity Systems IPA Provides Researchers with Genomic Insights Suggesting that Physical Activity Does Not Slow Muscle Aging
Date:3/21/2013

REDWOOD CITY, Calif., March 21, 2013 /PRNewswire/ -- Ingenuity® Systems, a leading provider of biomedical information and analysis solutions, today announced that its IPA technology was instrumental in elucidating a network of genetic drivers for aging. The networks determined, among other things, that muscle age was not primarily related to the biology of physical activity. The research was published in the journal PLOS Genetics in a paper from the laboratory of Professor James A. Timmons at Loughborough University in the United Kingdom (http://www.plosgenetics.org/doi/pgen.1003389).

"IPA is used at research institutions and pharmaceutical companies across the globe to generate new insights about biological systems and determine the biological meaning of scientific results. To date, there are over 7500 peer-reviewed publications using IPA," said Dr. Doug Bassett , Chief Scientific Officer and Chief Technical Officer of Ingenuity Systems. "Dr. Timmons' work clearly shows how IPA can help scientists make significant insights on their research."

Previously, research had hypothesized that resistance exercise contributed to a reverse of the aging process, yet the work carried out by Dr. Timmons' lab demonstrated that response to exercise is highly variable in humans and that pre-existing gene expression levels can predict future response to exercise. The paper also identified biological molecules that may drive the response to physical activity.

The new work coupled analysis with Ingenuity's IPA software and microarray data generated both by Dr. Timmons' laboratory as well as data sets from published literature. The analysis determined that the genetic regulators of age-related genes were distinct and unrelated to the regulators of exercise-influenced genes.

'/>"/>
SOURCE Ingenuity Systems
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Ingenuity Systems Announces Compliance with HIPAA
2. Ingenuity Systems Announces Curation of All Human Disease Implicated Genetic Variation
3. Ingenuity Systems and GeneInsight to Deliver an Interpretation and Reporting Workflow Solution to Clinical Laboratories
4. At RSNA, DR Systems Will Exhibit RIS, Reporting, Peer Review Systems
5. Clionsky Neuro Systems (CNS-Neuro) Announces Publication of Study Finding Elderly Patients Unable to Recognize Their Memory Loss
6. Dicom Systems and USARAD.com Announce Partnership and Introduce Beta Version of XMRI.com, New System by USARAD.com
7. BioPower Systems Awarded $5 Million from Victorian Government
8. Varian Medical Systems Schedules First Quarter FY2012 News Release and Conference Call
9. Quanterix Develops Microfluidic Consumable That Will Enable Next Generation Molecular Diagnostic Systems based on Single Molecule Array Technology
10. CMC Biologics Strengthens its Innovative Biomanufacturing Technology Portfolio in Continuous Perfusion Systems
11. MarketsandMarkets: Global Clinical Trial Management Systems Market Worth $1300.4 Million by 2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Wednesday of last week RENU 28, the world's first and ... for purchase in Australia and New Zealand, and the response ... is, if you think about the definition of aging, it's ... within your body. If you think about the definition of ... What RENU 28 does is it works with these tiny ...
(Date:8/20/2014)... Fla. , Aug. 20, 2014 ... will host a conference call to provide an ... 2014Time:4:30 p.m. Eastern daylight timeDial-in numbers:(888) 505-4369 (U.S. ... 9126599 Live web cast: www.neurotropebioscience.com , under "Investor ... hours after completion through September 2, 2014 at ...
(Date:8/20/2014)... August 20, 2014 Not long ago, ... studies should be performed late in the development cycle ... But current regulatory trends suggest that, like many things ... rise. In recent years, multiple drug sponsors have been ... address specific questions during phase I/II. It’s not only ...
(Date:8/19/2014)... 20, 2014 One of the ... is an inadequate vascular supply. Nutrient and gas ... tissues is critical for successful regeneration and integration ... mitigate deficiencies in vascularization and promote angiogenesis in ... optimizing scaffold design and architecture, and enhancing scaffolds ...
Breaking Biology Technology:RENU 28 Skin Care Now Available in Australia and New Zealand 2Neurotrope To Host Conference Call 2Are Extractable and Leachables going Phase-Appropriate? New Webinar Hosted by Xtalks 2Vascularization in Tissue Engineering Highlighted at 12th New Jersey Symposium on Biomaterials Science 2
... N.J., Oct. 4 In conjunction with,its third quarter 2007 ... 24), Covance Inc. (NYSE: CVD ) is pleased to ... will be broadcast,live over the Internet on Thursday, October 25 ... Quarter 2007 Earnings Webcast and Slide Presentation When: ...
... Inc.,(NYSE: SMA ), an independent provider of ... medical markets, announced today that the Audit,Committee of ... review of,apparent irregularities with respect to the Company,s ... unit. The review follows a,report by management earlier ...
... today announced that Solomon Steiner, Chairman and CEO of Biodel,will ... San,Francisco, CA on October 11th at 11:00 AM PT. ... webcast of the,presentation in the investor relations section of Biodel,s ... be available for,14 days. About Biodel Inc. Biodel ...
Cached Biology Technology:Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement 2Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement 3Biodel Inc. to Present at BIO InvestorForum 2007 Conference on October 11, 2007 2
(Date:8/21/2014)... smog-producing toxins in past decade, GTA still violates ... that while the Greater Toronto Area (GTA) has ... to smog, the city continues to violate the ... can cause or aggravate health problems such as ... a set of complex photochemical reactions involving volatile ...
(Date:8/21/2014)... 2014 Nxt-ID, Inc. (OTCQB: NXTD), a biometric ... announced today that its shares of common stock and ... in its proposed underwritten public offering of common stock ... Nasdaq Capital Market, subject to closing of its proposed ... and will trade under the symbol "NXTD" and "NXTDW," ...
(Date:8/21/2014)... are the ultimate source of all organic matter that ... algae, too, to suck up climate-warming carbon dioxide from ... the ocean. Now, by using a combination of satellite ... viruses infecting those algae are driving the life-and-death dynamics ... essentially the same, and this has important implications for ...
Breaking Biology News(10 mins):Despite a significant reduction in smog-producing toxins, the Greater Toronto Area still violates Canada's standards for ozone air pollution 2Nxt-ID Approved for NASDAQ Capital Market Listing 2Nxt-ID Approved for NASDAQ Capital Market Listing 3Viruses take down massive algal blooms, with big implications for climate 2
... Boston, MA - Tiny particles only billionths of a meter ... human haircould offer big hope in a small package to the ... everything from jewelry to coins and cell phones, say scientists at ... issue of Nature Nanotechnology, the team will report a ...
... the largest study of its kind, researchers from a consortium ... linked to late-onset Alzheimer,s disease. Each of these genes adds ... the disease, and together they offer a portal into the ... to determine who is at risk of developing the disease, ...
... Medicine researchers are part of a consortium that has identified ... a person developing Alzheimer,s disease later in life. The ... The consortium also contributed to the identification of a ... United States and Europe. "Mount Sinai has unique resources ...
Cached Biology News:Nanoparticles offer hope for common skin allergy 2Nanoparticles offer hope for common skin allergy 3Alzheimer’s disease consortium identifies four new genes for Alzheimer’s disease risk 2Alzheimer’s disease consortium identifies four new genes for Alzheimer’s disease risk 34 new genes identified for Alzheimer's disease risk 2
Bovine Serum Available Anticoagulants: N-02: Citrate N-04: Heparin (Na) N-06: K2EDTA N-08: Potassium Oxalate N-10: EDTA (Na) N-03: Alsevers N-05: ACD N-07: CPD N-09: K3EDTA N-11:...
...
... deuterium atoms at the 9, 10, 12, and ... an internal standard for the quantification of 13(S)-HODE ... by incubation of linoleic acid with plant and ... the adhesion of tumor cells to the endothelium ...
...
Biology Products: